Apigenin cannot affect NF-kB expression in the human non-small cell lung cancer cell lines (A549), but it can prevent the translocation of NF-kB from the cytoplasm to the nucleus, resulting in the inhibition of apoptosis-blocking target genes. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.